HEIDI ABDELMAGUID: Open Payments
NPI 1578330866 · DENVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $50 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $85 |
| MDD US Operations, LLC | 3 | $53 |
| UCB, Inc. | 2 | $35 |
| Eisai Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $32 |
| ARGENX US, INC. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: UBRELVY, Apokyn, Leqembi, KISUNLA, VYVGART HYTRULO, Nayzilam, HYQVIA, Briviact.
Industry payments across NJ — which companies pay providers there.
